Abstract
Introduction

58
Viral synergism occurs commonly in the nature when co-infection of two or more with neoplasia ( Fig 1E) .
147
ALV-J synergizes REV to enhance pathogenicity and tumorigenesis
148
We established the animal model of co-inoculation of ALV-J and REV in allantoic 149 cavity of fertilized SPF eggs at 6-day of embryonic age. The hatching rates, weights,
150
H&E staining and qRT-PCR were used for confirming the synergistic pathogenicity showed that ALV-J synergized with REV to further decrease the hatching rate (Table   8   153 2). After hatching, both ALV-J and REV synergized with each other and further
154
decreased the weights of chicken (Fig 2A) (Fig 2C) , respectively, and ALV-J increased REV by 5.62-, 1.52-, 3.23-, 3.07-and 2.37-fold in the corresponding organs (Fig 2D) , respectively. Further,
165
some additional white nodules were observed in endocardium of co-infection group
166
( Fig 2E) . H&E staining results showed these white endocardial nodules were fibroma
167
( Fig 2E) . Collectively, co-infection of ALV-J and REV leads to induction of 168 inflammation and tumorigenesis.
169
ALV-J synergizes with REV to activate KIAA1199 and inhibit miR-147
170
To explore the synergistic tumorigenesis mechanism induced by ALV-J and REV,
171
CEFs infected with ALV-J, REV or both were analyzed using iTRAQ quantitative differentially expressed proteins in co-infected cells (Fig 3A) . 
230
To further determine whether NF-κB is required for induction of KIAA1199 and 231 EGFR, we constructed and transfected the NF-κB p65 shRNAs into the DF-1 cells.
232
Indeed, when NF-κB p65 was knockdown, the RNA levels of KIAA1199 and EGFR
233
were decreased (Fig 6A, B expression in CEF in a dose-dependent manner (Fig 7B and 7C) . On the contrary, a 244 miR-147 inhibitor up-regulated the endogenous KIAA1199 expression level in a dose-245 dependent manner (Fig 7D) . Bioinformatics analysis identified one putative miR-147 246 binding site at the KIAA1199 3'UTR ( Fig 7E) . Mutation of this site abolished the miR-247 147 inhibitory effect on KIAA1199 3'UTR reporter activity (Fig 7F) . These data 248 suggest that miR-147 directly targets KIAA1199.
249
Interestingly, previous study showed miR-147 is a member of suppressors for NF-κB p50 (Fig 7G) . Further, NF-κB p50 3'UTR luciferase reporter assay showed that 256 miR-147significantly inhibited the activity of NF-κB p50 3'UTR reporter but not that of 257 the control reporter (Fig 7H) . MiR-147 inhibited the activity of the NF-κB 3'UTR 258 reporter and the NF-κB p50 expression in CEF in a dose-dependent fashion ( Fig 7C   259 and I). A miR-147 inhibitor up-regulated the NF-κB p50 expression level in a dose-260 dependent manner (Fig 7D) . Mutation of this site abolished the miR-147 inhibitory 261 effect on NF-κB p50 3'UTR reporter activity (Fig 7J) . These data suggest that miR-262 147 also directly targets NF-κB p50 besides KIAA1199.
263
Discussion
264
In this study, a specific synergism was observed in ALV-J and REV co-infected the 3'UTR region sequences of NF-κB p50 and KIAA1199 (Fig 8) .
277
Previous studies on the mechanisms of tumor initiation and progression by 
322
In this study, the expressions of miR-147 were decreased in kidney, bone marrow 323 and heart, which were correlated with the oncogene KIAA1199 activation by co- Fabricius and heart to detect the viral RNA, KIAA1199, EGFR or miR-147. GenePharma (Shanghai, China).
411
MiRNA mimics and inhibitors
412
The sequence of commercially available miR-147 mimics was 5'- The protocol was conducted as described in the previous study (65).
439
Confocal microscopy assay
440
For confocal microscopy assay, the cells were washed three times with PBS (137mM 441 NaCl, 2.7mM KCl, 10mM Na 2 HPO 4 , and 2mM KH 2 PO 4 ) and were fixed in fixative (1ml anti-KIAA1199 antibody (1:100) was used for the primary reaction.
459
Immunoperoxidase staining was performed using the LSAB kit (Dako, Glostrup, 
463
The immunolabelled tissues were evaluated by using a semi-quantitative score of 464 the intensity and extent of the staining according to an arbitrary scale (47).
465
Real-time quantitative reverse transcription polymerase chain reaction
466
The specific primer sequences of KIAA1199, NF-κB p50, NF-κB p65, EGFR and
467
GAPDH were listed in Supplementary Table S1 . Total RNA from CEF either Mock, Table S1 ). All values were normalized to the endogenous control software. All values were normalized to the endogenous control U6 to control for 483 variation. The specific primer of U6 was described in Supplementary Table S1 .
484
Assays were performed in triplicate and average threshold cycle (CT) values were 485 used to determine relative concentration differences based on the ΔΔCT method of 486 relative quantization described in the manufacturer's protocol.
487
Cell Counting Kit (CCK-8) for cell proliferation assay
488
Cell Count Kit-8 was purchased from Solarbio (Beijing, China) and used to examine 489 cell proliferation according to the manufacturer's instructions.
490
ELISA for NF-κB p65 and P-IκBα assay
491
Chicken NF-κB p65 ELISA kit and Chicken NF-κB P-IκBα ELISA kit were purchased 492 from Senbeijia (Nanjing, China) and used to assay the expression of NF-κB p65
493
according to the manufacturer's instructions.
494
Statistical analysis
495
Results are presented as the mean ± standard deviation(s).The T test and ONEWAY
496
ANOVA test was performed using SPSS 13.0 statistical software. A P value less than 497 0.05 was considered statistically significant.
498
Accession numbers
499
The Illumina small RNA deep sequencing data for the reported miRNAs has been 500 deposited with the NCBI GEO under accession number GSE109105.
501
Ethics Statement
502
The experiment was carried out in strict accordance with the recommendations in the 
